Site Search:

ABOUT US > OUR SCIENTIFIC DIRECTORS


Richard R. Love, M.D., M.S.

Scientific Director

Dr. Love is a medical researcher whose focus is on hormonal control of breast cancer. For the last 15 years his NIH and Breast Cancer Research Foundation-funded research has been done in collaboration with colleagues in Vietnam, and more recently in the Philippines, Morocco and Bangladesh.

His clinical trial of adjuvant surgical oophorectomy and tamoxifen established a new global standard of care, of significant importance to 500,000 poor women diagnosed with breast cancer annually around the world.

Currently a major new focus of Dr. Love’s and IBCRF's attention is in developing a model population-based program to reduce morbidity and mortality from breast cancer among the 7 million women residing in the Khulna division of Bangladesh. This program involves educational, service and research projects, in partnership with a rural information technology non-governmental organization. To achieve service sustainability, the program is being developed as a group of “social businesses”, following the entrepreneurial ideas and with the assistance of Muhammad Yunus, the Bangladeshi Nobel Peace Prize Laureate.

Publications:

Review a list of Dr. Love's publications
.

Ophira Ginsburg

Deputy Scientific Director

Ophira Ginsberg
Dr. Ophira Ginsburg is an assistant professor in the department of medicine and in the Dalla Lana School of Public Health at the University of Toronto. She is head of the Cancer Prevention and Screening Program, and director of Familial Oncology at the Central East Regional Cancer Program, RS McLaughlin Durham Regional Cancer Centre. As an Adjunct Scientist at the Women's College Research Institute, she works closely with Dr. Steven Narod and other members of the Familial Breast Cancer Research Unit.

As Deputy Scientific Director of the International Breast Cancer Resaerch Foundation, Dr. Ginsburg works to bring together scientists and care-providers from all corners of the world to improve the health and well-being of women living with breast cancer, regardless of nationality, socio-political context and resource-level.

Research and Academic Interests:

Dr. Ginsburg has a clinical and research background in breast cancer genetics and medical oncology. Since 2004, her research has focused on understanding population differences in breast cancer risk and outcomes. Together with researchers in Canada (
Dr. Steven Narod, WCRI), the US (Dr Richard Love, Ohio State University, NIH) and in developing countries such as Vietnam, the Philippines and Bangladesh, Dr. Ginsburg has helped to develop an international network of teams interested in improving breast cancer care in under-served communities at home and abroad.

Dr. Ginbsurg's long term goal is to develop a more evidenced-based approach to the looming public health crisis of breast cancer in the developing world. It is her hope that by studying breast cancer risk factors, treatments and outcomes in other populations, particularly in developing countries these partnerships will better serve the needs of migrant and other non-Caucasian populations at home.

Publications:

Review a list of
Ophira Ginsburg's peer-reviewed publications as indexed by the National Library of Medicine.


MORE SCIENCE IN THE SERVICE TO MAN

A theme of Dr. Love’s work is social justice, and the need for activities to better address public health-population challenges in the face of the evolution of cancer medicine as big business.

From left: Rashed Ahmed (Amader Gram), Dr. Richard R. Love, Professor Muhammad Yunus (Nobel Peace Laureat), Reza Salim (Amader Gram)
To this end Dr. Love publishes articles in peer-reviewed journals, and lectures widely to lay and professional audiences, more outside than within the United States. In the United States he has called for significant increases in global public health oncology research (“micro-approaches”), comparable to the current efforts in communicable diseases (ASCO Breast Cancer Symposium September 7, 2008; U.S. Department of State and Avon Foundation Breast Cancer Global Congress October 15, 2008).

CURRENT CLINICAL TRIALS

Dr. Love has three major clinical trials investigating new “public health” (i.e. easily replicable, practical, limited toxicity and low cost) treatments for breast cancer in 9 countries; nearly 1,000 usually forgotten poor women have entered these trials to date. He is working with several American and Canadian researchers to develop a larger portfolio of similar international collaborative-public health studies. To carry out this work Dr. Love spends 40% of his time abroad.

For overviews of our current research projects, click here

 

Bangladesh China Indonesia
Malaysia Canada Nigeria
Philippines United States Vietnam

INTERNATIONAL
BREAST CANCER
RESEARCH FOUNDATION
660 John Nolen Dr.,
Madison, WI 53713
608.268.3077 Office
608.246.3019 Fax
608.444.4397 Cell
maureen@ibcrf.org